VolitionRx
Ltd. is a life sciences company focused on bringing to market its inexpensive,
accurate, and scalable cancer detection blood tests. The company intends to use
its NuQR suite of products to fill a looming void in cancer diagnostic testing,
for which there currently is only one blood test in common clinical use.
NuQR
is based on VolitionRx’s proprietary NucleosomicsR technology, capable of
measuring and identifying nucleosome structures in the blood. The company has
secured strong intellectual property protection for its products, further
strengthened by patent applications in the United States, Europe and worldwide.
Following ongoing clinical trials and regulatory approval, VolitionRx will
market its diagnostic and screening tests for individual cancers under the NuQR
brand.
The
company is currently conducting clinical trials for its first product, a
diagnostic test for colorectal cancer. Colorectal cancer is the third most
common cancer in the United States – current tests are expensive, invasive and
unpleasant, resulting in a significant need for an improved alternative for
colorectal diagnoses.
VolitionRx’s
primary office and laboratory are based in Namur, Belgium, from which the
company’s strong team of professionals spearhead corporate initiatives. The
company’s executive management team is further supported by a scientific
advisory board staffed with senior scientists from around the world, as well as
a highly experienced board of directors.
For
more information, visit www.volitionrx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
